ESH MM 2018 | Where will we be in MM management 5 years from now?
Elena Zamagni, MD, PhD, of the University of Bologna, Bologna, Italy, discusses the future landscape of multiple myeloma (MM) management at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France. With excellent diagnostic and analytical tools available for examining the bone marrow and beyond, Dr Zamagni believes we are well on the way to personalized treatment for MM. She highlights the increasing success of treatment and measurable residual disease measurement for MM patients in reaching complete remission.
Get great new content delivered to your inboxSign up